日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Exposure-response relationship of nivolumab and ipilimumab in patients with metastatic renal cell carcinoma from the randomised phase 2 BIONIKK study

来自随机 II 期 BIONIKK 研究的转移性肾细胞癌患者中纳武利尤单抗和伊匹木单抗的暴露-反应关系

Blanchet, Benoit; Puszkiel, Alicja; Jouinot, Anne; Bennamoun, Mostefa; Maillet, Denis; Borchiellini, Delphine; Laguerre, Brigitte; Pannier, Diane; Gross-Goupil, Marine; Chevreau, Christine; Barthélémy, Philippe; Tournigand, Christophe; Coquan, Elodie; Gravis, Gwenaelle; Lepicard, Eve; Fridman, Wolf Herman; Sautes-Fridman, Catherine; Oudard, Stéphane; Sun, Cheng-Ming; Vano, Yann-Alexandre

HPV circulating tumor DNA to monitor response to pembrolizumab and vorinostat combination in patients with advanced HPV-related squamous-cell carcinomas

检测HPV循环肿瘤DNA以监测晚期HPV相关鳞状细胞癌患者对帕博利珠单抗和伏立诺他联合治疗的反应

Filippini, D M; Cabarrou, B; Dupain, C; Halladjian, M; Coquan, E; Sablin, M-P; Mazzarella, L; Francisco, M; Servant, N; Tonini, M M; Hundt, A F; Castel-Ajgal, Z; You, B; Bigot, F; Ghiringhelli, F; Vansteene, D; Gomez-Roca, C; Cousin, S; Lambert, A; Saada-Bouzid, E; Durando, X; Abdeddaim, C; Borel, C; Chaltiel, R; Borcoman, E; Legrand, F; Bernhart, S; Jimenez, M; Bièche, I; Filleron, T; Le Tourneau, C; Kamal, M; Jeannot, E

Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trial

帕博利珠单抗联合伏立诺他治疗复发和/或转移性鳞状细胞癌患者的疗效:一项 II 期篮式试验

Borcoman, Edith; Cabarrou, Bastien; Francisco, Miguel; Bigot, Frédéric; Ghiringhelli, François; Vansteene, Damien; Legrand, François; Halladjian, Maral; Dupain, Célia; Le Saux, Olivia; Coutzac, Clelia; Borel, Christian; Chaltiel, Raphael; You, Benoit; Gomez-Roca, Carlos; Cousin, Sophie; Coquan, Elodie; Lambert, Aurélien; Saada-Bouzid, Esma; Durando, Xavier; Saint-Ghislain, Mathilde; Frige, Gianmaria; Guerini-Rocco, Elena; Tonini, Maria Manuela; Bièche, Ivan; Castel-Ajgal, Zahra; Marret, Grégoire; Sablin, Marie-Paule; Jeannot, Emmanuelle; Andre, Fabrice; Filleron, Thomas; Jimenez, Marta; Mazzarella, Luca; Servant, Nicolas; Kamal, Maud; Le Tourneau, Christophe

Durvalumab and tremelimumab in combination with metronomic oral vinorelbine for recurrent advanced cervical cancer: an open-label phase I/II study

Durvalumab 和 tremelimumab 联合节拍式口服长春瑞滨治疗复发性晚期宫颈癌:一项开放标签 I/II 期研究

Frenel, Jean-Sébastien; Mathiot, Laurent; Cropet, Claire; Borcoman, Edith; Hervieu, Alice; Coquan, Elodie; De La Motte Rouge, Thibault; Saada-Bouzid, Esma; Sabatier, Renaud; Lavaud, Pernelle; Jimenez, Marta; Legrand, François; Le Saux, Olivia; Charafe, Emmanuelle; Gonçalves, Anthony

MOVIE phase II trial of tremelimumab plus durvalumab combined with metronomic oral vinorelbine in patients with head and neck cancer

MOVIE II期临床试验,评估tremelimumab联合durvalumab和节拍式口服长春瑞滨治疗头颈癌患者的疗效

Borcoman, E; Hervieu, A; Cropet, C; Coquan, E; Guigay, J; Rolland, F; Bernadach, M; Charafe, E; Legrand, F; Dassé, E; Le Tourneau, C; Gonçalves, A

Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinoma

NeoPembrOv试验的免疫组学纵向分析揭示了高级别卵巢癌免疫耐药的驱动因素

Le Saux, Olivia; Ardin, Maude; Berthet, Justine; Barrin, Sarah; Bourhis, Morgane; Cinier, Justine; Lounici, Yasmine; Treilleux, Isabelle; Just, Pierre-Alexandre; Bataillon, Guillaume; Savoye, Aude-Marie; Mouret-Reynier, Marie-Ange; Coquan, Elodie; Derbel, Olfa; Jeay, Louis; Bouizaguen, Suliman; Labidi-Galy, Intidhar; Tabone-Eglinger, Séverine; Ferrari, Anthony; Thomas, Emilie; Ménétrier-Caux, Christine; Tartour, Eric; Galy-Fauroux, Isabelle; Stern, Marc-Henri; Terme, Magali; Caux, Christophe; Dubois, Bertrand; Ray-Coquard, Isabelle

Neoadjuvant and adjuvant pembrolizumab in advanced high-grade serous carcinoma: the randomized phase II NeoPembrOV clinical trial

新辅助和辅助帕博利珠单抗治疗晚期高级别浆液性癌:随机 II 期 NeoPembrOV 临床试验

Ray-Coquard, Isabelle L; Savoye, Aude-Marie; Schiffler, Camille; Mouret-Reynier, Marie-Ange; Derbel, Olfa; Kalbacher, Elsa; LeHeurteur, Marianne; Martinez, Alejandra; Cornila, Corina; Martinez, Mathilde; Bengrine Lefevre, Leila; Priou, Frank; Cloarec, Nicolas; Venat, Laurence; Selle, Frédéric; Berton, Dominique; Collard, Olivier; Coquan, Elodie; Le Saux, Olivia; Treilleux, Isabelle; Gouerant, Sophie; Angelergues, Antoine; Joly, Florence; Tredan, Olivier

Carboplatin in metastatic castration-resistant prostate cancer patients with molecular alterations of the DNA damage repair pathway: the PRO-CARBO phase II trial

卡铂治疗伴有DNA损伤修复通路分子改变的转移性去势抵抗性前列腺癌患者:PRO-CARBO II期试验

Coquan, Elodie; Penel, Nicolas; Lequesne, Justine; Leman, Raphaël; Lavaud, Pernelle; Neviere, Zoé; Brachet, Pierre-Emmanuel; Meriaux, Emeline; Carnot, Aurélien; Boutrois, Jérémy; Castera, Marie; Goardon, Nicolas; Muller, Etienne; Leconte, Alexandra; Thiery-Vuillemin, Antoine; Clarisse, Bénédicte; Joly, Florence

The impact of introducing deep learning based [(18)F]FDG PET denoising on EORTC and PERCIST therapeutic response assessments in digital PET/CT

引入基于深度学习的[(18)F]FDG PET去噪技术对数字PET/CT中EORTC和PERCIST治疗反应评估的影响

Weyts, Kathleen; Lequesne, Justine; Johnson, Alison; Curcio, Hubert; Parzy, Aurélie; Coquan, Elodie; Lasnon, Charline

Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study

法国肿瘤早期临床试验机会不平等因素:EGALICAN-2 研究结果

Charton, E; Baldini, C; Fayet, Y; Schultz, E; Auroy, L; Vallier, E; Italiano, A; Robert, M; Coquan, E; Isambert, N; Moreau, P; Touzeau, C; Le Tourneau, C; Ghrieb, Z; Kiladjian, J-J; Delord, J-P; Gomez Roca, C; Vey, N; Barlesi, F; Lesimple, T; Penel, N; Soria, J-C; Massard, C; Besle, S